Ciba Ckd Preferential Offer To Hind Ciba Staff

The company is also making a private placement to financial institutions, finance companies, mutual funds etc.

Set up to manufacture anti-TB drug rifampicin, Ciba CKD is offering 31,00,000 equity shares of Rs 10 each for cash at a premium of Rs 30 per share. It is offering 40,30,000 equity shares of Rs 10 each for cash at a premium of Rs 30 on private placement basis.

The preferential offer is subject to three year lock-in period from the date of allotment. N Shah, general manager and company secretary, Ciba CKD, said: The three year lock-in period would not be a deterrent to invest since Ciba enjoys a strong brand name.